A drug used to treat several types of cancer is also an effective treatment for aggressive forms of endometrial cancer, the second most common cancer in women worldwide, a new clinical trial shows. The endometrium is the inner lining of the uterus. “These findings suggest a long-term benefit to patients,” said lead researcher Dr. David… read on > read on >
A little about: Weekly Sauce
All Sauce from Weekly Sauce:
Wildfires Plus Heat Make Breathing Dangerous in America’s West
Wildfires and rising temperatures are exposing more and more Americans to an air pollution double-whammy of smoke and smog, a new study warns. Researchers found that over the past 20 years, a growing number of people in western states have been simultaneously exposed to high levels of two kinds of air pollution: Fine-particle pollution generated… read on > read on >
Progress on Lung Cancer Drives Overall Decline in U.S. Cancer Deaths
A new report offers hope on the lung cancer front: Patients are being diagnosed at an earlier stage in their disease and living longer due to better access to care, higher screening rates and improved treatments. And that is driving overall cancer rates down, researchers discovered. Still, lung cancer remains the leading cause of cancer… read on > read on >
Nearly 600,000 U.S. Kids Had COVID Last Week
In a sign that the highly contagious Omicron variant is sparing no one, a new report shows that new COVID-19 cases among U.S. children spiked to a high of more than 580,000 for the week ending Jan. 6, a 78% increase from the week before. “Since many children remain unvaccinated — or are too young… read on > read on >
As Omicron Rages, How Important Are Case Counts Anymore?
The record-breaking numbers surrounding the Omicron surge are dizzying, with so many Americans falling prey to the highly infectious COVID-19 variant. The United States reported more than 1.3 million COVID cases on Monday, the highest daily total recorded for any country in the world. The seven-day case average has tripled in two weeks, reaching more… read on > read on >
U.S. May Soon See Sharp Drop in Omicron Cases, Experts Say
The Omicron surge may have peaked in Britain and could be about to do the same in the United States, experts report. That’s because the COVID-19 variant first detected in South Africa in mid-November is so contagious that the variant may already be running out of people to infect, the Associated Press reported. In Britain,… read on > read on >
BinaxNOW Test Catches COVID Infection in Many People, Study Shows
Countering earlier concerns, a real-world study finds that a widely used at-home coronavirus test called BinaxNOW is as effective at detecting Omicron as other COVID-19 variants. The study of Abbot’s rapid antigen test included more than 700 people who visited a walk-up testing site in San Francisco. The test detected 65% of infections caught by… read on > read on >
White House to Give Schools 10 Million Free COVID Tests Every Month
In an effort to keep kids in classrooms, the White House announced Wednesday that 10 million free coronavirus tests will be provided to schools around the country every month while the wildly contagious Omicron variant continues to surge. President Joe Biden has been pushing for months to have schools stay open because the academic, social… read on > read on >
Medicaid Rules May Affect Americans’ Cancer Survival
The chance of someone who is covered by Medicaid surviving cancer may depend in part on where they live, a new analysis finds. In states that had lower Medicaid income eligibility limits, cancer survival rates were worse for cancers both in early and late stages compared to states with higher Medicaid income eligibility limits, American… read on > read on >
How Safe Is a ‘Holiday’ From Bone-Strengthening Meds?
People on bone-protecting drugs often take breaks from them for a few years. Now a new study finds that a “holiday” from the medication risedronate (Actonel) may come with a slightly increased risk of hip fracture. Researchers found that compared with a drug holiday from alendronate (Fosamax), taking a few years off from risedronate came… read on > read on >